# The Use of Teriparatide as an Adjunctive Therapy for the Treatment of Jones Fractures

> **NCT01173081** · PHASE4 · UNKNOWN · sponsor: **Ohio Orthopedic Center of Excellence** · enrollment: 38 (estimated)

## Conditions studied

- Fractures

## Interventions

- **DRUG:** Teriparatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01173081
- **Lead sponsor:** Ohio Orthopedic Center of Excellence
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-07
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2012-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01173081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01173081, "The Use of Teriparatide as an Adjunctive Therapy for the Treatment of Jones Fractures". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01173081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*